Premium
BCL‐XL exerts a protective role against anemia caused by radiation‐induced kidney damage
Author(s) -
Brinkmann Kerstin,
Waring Paul,
Glaser Stefan P,
Wimmer Verena,
Cottle Denny L,
Tham Ming Shen,
Nhu Duong,
Whitehead Lachlan,
Delbridge Alex RD,
Lessene Guillaume,
Smyth Ian M,
Herold Marco J,
Kelly Gemma L,
Grabow Stephanie,
Strasser Andreas
Publication year - 2020
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.15252/embj.2020105561
Subject(s) - biology , kidney , anemia , cancer research , immunology , medicine , genetics
Studies of gene‐targeted mice identified the roles of the different pro‐survival BCL‐2 proteins during embryogenesis. However, little is known about the role(s) of these proteins in adults in response to cytotoxic stresses, such as treatment with anti‐cancer agents. We investigated the role of BCL‐XL in adult mice using a strategy where prior bone marrow transplantation allowed for loss of BCL‐XL exclusively in non‐hematopoietic tissues to prevent anemia caused by BCL‐XL deficiency in erythroid cells. Unexpectedly, the combination of total body γ‐irradiation (TBI) and genetic loss of Bcl‐x caused secondary anemia resulting from chronic renal failure due to apoptosis of renal tubular epithelium with secondary obstructive nephropathy. These findings identify a critical protective role of BCL‐XL in the adult kidney and inform on the use of BCL‐XL inhibitors in combination with DNA damage‐inducing drugs for cancer therapy. Encouragingly, the combination of DNA damage‐inducing anti‐cancer therapy plus a BCL‐XL inhibitor could be tolerated in mice, at least when applied sequentially.